Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04891705
Other study ID # US-Lung AI-11237
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 11, 2021
Est. completion date December 14, 2023

Study information

Verified date November 2023
Source Philips Clinical & Medical Affairs Global
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is being conducted to collect image data and relevant clinical data from medical records of patients with suspicion of lung consolidation or pleural effusion. The information will be used to test the performance of Artificial Intelligence (AI) in identification of features associated with the above lung conditions.


Description:

This is a prospective, observational, multi-center, post-market clinical study. Enrollment will continue (up to a maximum of 500 adult subjects and up to 300 pediatric subjects) until diagnostic LUS exams are acquired for each of the following groups: Approximately 500 Adult subjects targeting: - Approximately 175 exams from patients positive for lung consolidation - Approximately 175 exams from patients positive for pleural effusion - Approximately 150 exams from patients negative for both conditions Approximately 300 pediatric subjects targeting: - Approximately 150 exams from patients positive for lung consolidation - Approximately 150 exams from patients negative for lung consolidation


Recruitment information / eligibility

Status Completed
Enrollment 554
Est. completion date December 14, 2023
Est. primary completion date December 14, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. Subjects presenting to the Emergency Department, admitted to the hospital, or seen in the outpatient setting with suspicion of pleural effusion or lung consolidation who received chest imaging to include chest X-ray or CT, or for whom chest X-ray or CT are planned. Suspicion of pleural effusion or lung consolidation may be based upon imaging findings or presentation of symptoms including (but not limited to) dyspnea, hypoxia, tachypnea, rales, or dullness. 2. All attempts should be made for subjects to undergo scanning of 14 lung zones (adults) and 12 lung zones (pediatrics). Attempts should also be made to capture all required lung zones in adults and pediatrics. Instances where all zones cannot be captured need to be documented and reason for inability to scan them provided in EDC. See Section 8.1.3 Lung Ultrasound Exams. 3. Subject is willing to provide informed consent (or assent where age appropriate) to participate in the study. Subjects under 18 years of age require informed consent of a parent or guardian and assent as required by institutional IRB. 4. Weight of subject is greater than or equal to 10 kg. Exclusion Criteria: 1. Subject has pathology precluding safe and pain-free ultrasound probe placement such as burn, significant soft tissue injury or surgical incisions. 2. Current imprisonment. 3. Pregnancy (self-reported) 4. Subjects with breast implants 5. Prior pleurodesis procedure. 6. History of severe lung disease and home oxygen use 7. Presence of subcutaneous air that precludes imaging 8. Body Mass Index (BMI) > 40 9. Significant scoliosis (Cobb angle = 20 degrees). 10. Pediatric subjects with chronic lung diseases other than asthma. 11. Pediatric subjects on chronic respiratory support (i.e., nasal canula, CPAP, BiPAP, or tracheostomy).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Lung Ultrasound Scan
Ultrasound scan of subjects in up to 14 lung zones

Locations

Country Name City State
United States University of Colorado Hospital Aurora Colorado
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States Prisma Health Greenville Memorial Hospital Greenville South Carolina
United States Yale School of Medicine New Haven Connecticut
United States Arizona Emergency Medical Research Center Tucson Arizona

Sponsors (1)

Lead Sponsor Collaborator
Philips Clinical & Medical Affairs Global

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The study data will be used to support future performance assessments for Artificial Intelligence based algorithms as described by FDA guidance for Computer Assisted Detection and Diagnostic Devices Discharge up to 30 days (Single visit)
See also
  Status Clinical Trial Phase
Completed NCT04159831 - A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions Phase 2
Recruiting NCT02891642 - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Completed NCT02232841 - Electrical Impedance Imaging of Patients on Mechanical Ventilation N/A
Completed NCT02045641 - Pleural and Pericardial Effusion Following Open Heart Surgery N/A
Completed NCT01948076 - Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination N/A
Completed NCT01416519 - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation N/A
Completed NCT01560078 - Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion N/A
Recruiting NCT05759117 - Prospective Evaluation of Patients With Pleural Effusion
Recruiting NCT05910112 - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed NCT03896672 - Clinical Implementation of the Use of Positive Pressure in Chest Drainage N/A
Active, not recruiting NCT06075836 - AI Assisted Detection of Chest X-Rays
Recruiting NCT03728491 - Education and Training Competences in Thoracic Ultrasound N/A
Not yet recruiting NCT03260088 - Evaluation Of Pleural Effusion At Assiut University Hospital N/A
Completed NCT03535883 - The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants
Completed NCT03296280 - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed NCT03661801 - Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Completed NCT01778270 - Not Invasive Monitoring of Pleural Drainage N/A
Terminated NCT00402896 - Malignant Pleural Effusion With ZD6474 Phase 2
Recruiting NCT00103766 - Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion N/A
Completed NCT03327688 - Point-of-care Ultrasound in Finland N/A